MET
58
2
AN
49
2
DHI
36
3
IRM
33
5
GME
61
2
ADBE
50
3
STT
48
4
AEP
45
5
HST
53
4
MU
42
14
CTSH
55
3
TAP
57
6
COP
36
2
LNC
28
3
FCX
44
4
TGNA
48
5
LMT
29
-5
HES
49
2
PLD
35
5
PSX
24
2
MET
58
2
AN
49
2
DHI
36
3
IRM
33
5
GME
61
2
ADBE
50
3
STT
48
4
AEP
45
5
HST
53
4
MU
42
14
CTSH
55
3
TAP
57
6
COP
36
2
LNC
28
3
FCX
44
4
TGNA
48
5
LMT
29
-5
HES
49
2
PLD
35
5
PSX
24
2
Financhill
Back

NeuroOne Medical Technologies 10K Form

Sell
41

NMTC
NeuroOne Medical Technologies

Last Price:
$0.74
Seasonality Move:
66.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-12 10K NMTC/NeuroOne Medical Technologies Annual
2021-01-28 10K NMTC/NeuroOne Medical Technologies Annual
2020-12-09 10K NMTC/NeuroOne Medical Technologies Annual
2020-08-13 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-05-14 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-02-14 10Q NMTC/NeuroOne Medical Technologies Quarterly

Receive NMTC News And Ratings

See the #1 stock for the next 7 days that we like better than NMTC

NMTC Financial Statistics

Sales & Book Value

Annual Sales: $3.5M
Cash Flow: $-2.7M
Price / Cash Flow: 0
Annual Sales: $0.03
Price / Book: 28.45

Profitability

EPS (TTM): -0.46000
Net Income (TTM): $-12.3M
Gross Margin: $1.1M
Return on Equity: -335.54%
Return on Assets: -208.1%

NeuroOne Medical Technologies Earnings Forecast

Key NeuroOne Medical Technologies Financial Ratios

  • The Gross Profit Margin over the past 15 years for NMTC is 31.27%.
  • The Selling, General & Administrative Expenses for NMTC have been equal to 228.84% of Gross Profit Margin.
  • The Research & Development expenses have been 146.69% of Revenue.
  • The Interest Expense is -1.86% of Operating Income.
  • The Net Earning history of NMTC is -356.74% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

NeuroOne Medical Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NMTC
Website: n1mtc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.09
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NMTC Technical Analysis vs Fundamental Analysis

Sell
41
NeuroOne Medical Technologies (NMTC) is a Sell

Is NeuroOne Medical Technologies a Buy or a Sell?